investorscraft@gmail.com

Intrinsic ValueRockwood Strategic Plc (RKW.L)

Previous Close£301.00
Intrinsic Value
Upside potential
Previous Close
£301.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Rockwood Strategic Plc, operating under Gresham House Strategic plc, is a specialized investment fund focused on private and public equity investments in undervalued small-cap companies across the UK and Europe. The fund targets high-growth sectors such as financial services, media, ICT, digital technology, healthcare, and life sciences, with a preference for businesses valued under £250 million. Its investment strategy emphasizes PIPE (Private Investment in Public Equity), pre-IPO opportunities, and recovery capital, typically acquiring stakes between 5% and 25% through cash or share considerations. Rockwood employs a disciplined approach, selecting companies with strong fundamentals—such as high ROCE (>10%) and free cash flow yield (>10%)—while avoiding overleveraged or overvalued firms. The fund’s market positioning is distinct, leveraging its expertise in identifying mispriced assets in both public (FTSE All-Share, AIM-listed) and private markets, often targeting firms trading at steep discounts to historical highs. By focusing on long-term value creation, Rockwood aims to deliver a net IRR of 15%, supported by active portfolio management and selective follow-on investments. Its niche strategy differentiates it from broader private equity players, offering investors exposure to high-conviction, high-potential small-cap opportunities.

Revenue Profitability And Efficiency

Rockwood reported revenue of £3.83 million (GBp) for FY 2024, with net income of £2.9 million, reflecting a lean operational structure. Diluted EPS stood at 0.11 GBp, indicating modest but positive earnings per share. The negative operating cash flow of £524,000 suggests reinvestment or timing disparities in its investment activities, though the absence of capital expenditures and debt underscores disciplined capital allocation.

Earnings Power And Capital Efficiency

The fund’s earnings power is driven by its selective investment criteria, targeting companies with ROCE exceeding 10% and EBITDA multiples below 7x. Its cash position of £4.76 million provides liquidity for opportunistic investments, while the lack of debt enhances flexibility. The focus on free cash flow yield (>10%) aligns with its capital-efficient strategy, though realized returns depend on exit timing and market conditions.

Balance Sheet And Financial Health

Rockwood maintains a robust balance sheet with £4.76 million in cash and no debt, ensuring financial stability. The absence of leverage reduces risk, while the fund’s equity-based investments align with its long-term horizon. Its financial health is further supported by a dividend payout of 0.6 GBp per share, reflecting confidence in liquidity and portfolio performance.

Growth Trends And Dividend Policy

The fund’s growth is tied to its ability to identify and exit undervalued investments, with a target IRR of 15%. Its dividend policy, offering 0.6 GBp per share, signals a commitment to shareholder returns while retaining capital for reinvestment. Portfolio growth hinges on sectoral trends in tech, healthcare, and financial services, where Rockwood has concentrated its bets.

Valuation And Market Expectations

With a market cap of £99.4 million, Rockwood trades as a niche small-cap investment vehicle. Its beta of 1.11 suggests moderate sensitivity to market movements. Investors likely price in its specialized strategy and track record, though valuation multiples are less relevant given its focus on underlying portfolio performance rather than operating metrics.

Strategic Advantages And Outlook

Rockwood’s edge lies in its disciplined, high-conviction approach to small-cap investing, backed by rigorous selection criteria. The outlook depends on execution in exiting investments at target valuations, particularly in recovering markets. Sector tailwinds in digital tech and healthcare could amplify returns, while macroeconomic volatility remains a key risk.

Sources

Company description, financial data provided

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount